Mobile version of Hanspub

文章引用说明 更多>> (返回到该文章)

T. Mitsudomi, S. Morita, Y. Yatabe, et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): An open label, randomised phase 3 trial. Lancet Oncology, 2010, 11(2): 121-128.

被以下文章引用: